Nexalin Technology, Inc. Share Price
Equities
NXL
US65345B2016
Advanced Medical Equipment & Technology
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.25 USD | -2.34% | -10.18% | +206.20% |
05-10 | Nexalin Technology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-25 | Nexalin Technology Regains Compliance With Nasdaq Listing Requirement | MT |
Sales 2022 | 1.32M 105M | Sales 2023 | 111K 8.82M | Capitalization | 3.01M 240M |
---|---|---|---|---|---|
Net income 2022 | -1M -79.63M | Net income 2023 | -4M -319M | EV / Sales 2022 | -0.59 x |
Net cash position 2022 | 6.24M 497M | Net cash position 2023 | 2.94M 234M | EV / Sales 2023 | 0.6 x |
P/E ratio 2022 |
-2.46
x | P/E ratio 2023 |
-0.64
x | Employees | 6 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 77.08% |
1 day | -2.34% | ||
1 week | -10.18% | ||
Current month | -18.99% | ||
1 month | -37.40% | ||
3 months | +299.71% | ||
6 months | +264.56% | ||
Current year | +206.20% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 18/10/10 | |
Mark White
CEO | Chief Executive Officer | 62 | 31/12/17 |
David Owens
CTO | Chief Tech/Sci/R&D Officer | 63 | 31/12/16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Leslie Bernhard
CHM | Chairman | 80 | - |
Mark White
CEO | Chief Executive Officer | 62 | 31/12/17 |
Alan Kazden
BRD | Director/Board Member | 63 | 31/12/18 |
Date | Price | Change | Volume |
---|---|---|---|
13/05/24 | 1.24 | -3.16% | 20 140 |
10/05/24 | 1.28 | +10.34% | 66,030 |
09/05/24 | 1.16 | -4.13% | 31,622 |
08/05/24 | 1.21 | -6.92% | 41,031 |
07/05/24 | 1.3 | -5.80% | 36,062 |
Delayed Quote Nasdaq, May 13, 2024 at 04:51 pm
More quotes1st Jan change | Capi. | |
---|---|---|
+206.20% | 9.52M | |
+11.11% | 226B | |
+9.29% | 188B | |
+13.16% | 137B | |
+26.02% | 108B | |
+0.34% | 63.19B | |
+12.39% | 52.26B | |
+5.62% | 51B | |
+6.75% | 43.89B | |
+5.85% | 38.07B |
- Stock Market
- Equities
- NXL Stock